It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
In health examinations for local inhabitants in cadmium-polluted areas, only healthy people are investigated, suggesting that patients with severe cadmium nephropathy or itai-itai disease may be overlooked. Therefore, we performed hospital-based screening to detect patients with cadmium nephropathy in two core medical institutes in cadmium-polluted areas in Akita prefecture, Japan.
Methods
Subjects for this screening were selected from patients aged 60 years or older with elevated serum creatinine levels and no definite renal diseases. We enrolled 35 subjects from a hospital in Odate city and 22 from a clinic in Kosaka town. Urinary ß2-microglobulin and blood and urinary cadmium levels were measured.
Results
The criteria for renal tubular dysfunction and the over-accumulation of cadmium were set as a urinary ß2-microglobulin level higher than 10,000 μg/g cr. and a blood cadmium level higher than 6 μg/L or urinary cadmium level higher than 10 μg/g cr., respectively. Subjects who fulfilled both criteria were diagnosed with cadmium nephropathy. Six out of 57 patients (10.5% of all subjects) had cadmium nephropathy.
Conclusions
This hospital-based screening is a very effective strategy for detecting patients with cadmium nephropathy in cadmium-polluted areas, playing a complementary role in health examinations for local inhabitants.
Registration number
No. 6, date of registration: 6 June, 2010 (Akita Rosai Hospital), and No. 1117, date of registration: 26 December, 2013 (Akita University).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Department of Internal Medicine, Akita Rosai Hospital, Japan Organization of Occupational Health and Safe, Akita, Japan; Fukunaga Clinic, Akita, Japan
2 Department of Hygiene, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan; Department of Environmental Health Sciences, Akita University, Graduate School of Medicine, Akita, Japan; Department of Environmental and Preventive Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan
3 Kosaka-machi Clinic, Akita, Japan
4 Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
5 Department of Environmental Health Sciences, Akita University, Graduate School of Medicine, Akita, Japan
6 Department of Epidemiology and Environmental Health, Juntendo University Faculty of Medicine, Tokyo, Japan
7 Department of Hygiene, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan; Department of Epidemiology and Environmental Health, Juntendo University Faculty of Medicine, Tokyo, Japan
8 Department of Internal Medicine, Akita Rosai Hospital, Japan Organization of Occupational Health and Safe, Akita, Japan; Department of Emergency, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan